(R)-adrenaline increases expression ISO RGD:1305008 6480464 Epinephrine results in increased expression of SUCLG2 protein CTD PMID:19464573 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SUCLG2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of SUCLG2 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1305008 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SUCLG2 mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SUCLG2 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SUCLG2 mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression ISO RGD:1305008 6480464 2, 4-dinitrotoluene affects the expression of SUCLG2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:1305008 6480464 2, 6-dinitrotoluene affects the expression of SUCLG2 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of SUCLG2 mRNA CTD PMID:28973697 5-methyl-4-oxido-2-pyrazin-4-iumcarboxylic acid decreases expression ISO RGD:1312779 6480464 acipimox results in decreased expression of SUCLG2 mRNA CTD PMID:25352640 7H-xanthine multiple interactions ISO RGD:1305008 6480464 [Xanthine co-treated with XDH protein] results in decreased expression of SUCLG2 protein CTD PMID:19464573 9H-xanthine multiple interactions ISO RGD:1305008 6480464 [Xanthine co-treated with XDH protein] results in decreased expression of SUCLG2 protein CTD PMID:19464573 acetamide decreases expression ISO RGD:1305008 6480464 acetamide results in decreased expression of SUCLG2 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1312779 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SUCLG2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SUCLG2 mRNA CTD PMID:32699268 aflatoxin B1 affects expression ISO RGD:1312779 6480464 Aflatoxin B1 affects the expression of SUCLG2 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1312779 6480464 Aflatoxin B1 results in decreased methylation of SUCLG2 gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SUCLG2 mRNA CTD PMID:19770486 alpha-hexachlorocyclohexane increases expression ISO RGD:1305008 6480464 alpha-hexachlorocyclohexane results in increased expression of SUCLG2 mRNA CTD PMID:16940010 alpha-pinene multiple interactions ISO RGD:1312779 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SUCLG2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SUCLG2 mRNA CTD PMID:32699268 arsenous acid decreases expression ISO RGD:1312779 6480464 Arsenic Trioxide results in decreased expression of SUCLG2 mRNA CTD PMID:29633893 arsenous acid increases expression ISO RGD:1312779 6480464 Arsenic Trioxide results in increased expression of SUCLG2 protein CTD PMID:25419056 atrazine decreases expression ISO RGD:1312779 6480464 Atrazine results in decreased expression of SUCLG2 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of SUCLG2 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1312779 6480464 Benzoapyrene results in decreased expression of SUCLG2 mRNA CTD PMID:21632981 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1312779 6480464 7 more ... CTD PMID:19150397 bisphenol A multiple interactions ISO RGD:1305008 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SUCLG2 mRNA CTD PMID:26496021 bisphenol A affects expression ISO RGD:1312779 6480464 bisphenol A affects the expression of SUCLG2 mRNA CTD PMID:30903817 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of SUCLG2 promoter CTD PMID:27334623 bisphenol A increases expression ISO RGD:1305008 6480464 bisphenol A results in increased expression of SUCLG2 mRNA CTD PMID:25181051 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of SUCLG2 mRNA CTD PMID:26187450 cadmium dichloride increases expression ISO RGD:1312779 6480464 Cadmium Chloride results in increased expression of SUCLG2 protein CTD PMID:24527689 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SUCLG2 mRNA CTD PMID:20938992 chromium trinitrate decreases expression EXP 6480464 chromium nitrate results in decreased expression of SUCLG2 protein CTD PMID:22144121 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with RELB mutant form] results in decreased expression of SUCLG2 mRNA CTD PMID:23625948 clofibrate increases expression ISO RGD:1305008 6480464 Clofibrate results in increased expression of SUCLG2 protein CTD PMID:16470657 clofibric acid multiple interactions ISO RGD:1305008 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SUCLG2 mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO RGD:1312779 6480464 cobaltous chloride results in decreased expression of SUCLG2 mRNA CTD PMID:19376846 crocidolite asbestos affects expression EXP 6480464 Asbestos, Crocidolite affects the expression of SUCLG2 mRNA CTD PMID:19446018 cyclosporin A decreases expression ISO RGD:1312779 6480464 Cyclosporine results in decreased expression of SUCLG2 mRNA CTD PMID:20106945 dexamethasone increases expression ISO RGD:1312779 6480464 Dexamethasone results in increased expression of SUCLG2 mRNA CTD PMID:25047013 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SUCLG2 mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:1312779 6480464 Arsenic Trioxide results in increased expression of SUCLG2 protein CTD PMID:25419056 diarsenic trioxide decreases expression ISO RGD:1312779 6480464 Arsenic Trioxide results in decreased expression of SUCLG2 mRNA CTD PMID:29633893 dibutyl phthalate decreases expression ISO RGD:1305008 6480464 Dibutyl Phthalate results in decreased expression of SUCLG2 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SUCLG2 mRNA CTD PMID:17361019 , PMID:21266533 dorsomorphin multiple interactions ISO RGD:1312779 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin multiple interactions EXP 6480464 sodium nitrate inhibits the reaction [Doxorubicin results in decreased expression of SUCLG2 protein] CTD PMID:21251210 doxorubicin decreases expression ISO RGD:1312779 6480464 Doxorubicin results in decreased expression of SUCLG2 mRNA CTD PMID:29803840 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of SUCLG2 mRNA, Doxorubicin results in decreased expression of SUCLG2 protein CTD PMID:21251210 , PMID:26873546 ethanol increases expression EXP 6480464 Ethanol results in increased expression of SUCLG2 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1312779 6480464 Ethyl Methanesulfonate results in decreased expression of SUCLG2 mRNA CTD PMID:23649840 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 formaldehyde decreases expression ISO RGD:1312779 6480464 Formaldehyde results in decreased expression of SUCLG2 mRNA CTD PMID:23649840 fumonisin B1 decreases expression EXP 6480464 fumonisin B1 results in decreased expression of SUCLG2 mRNA CTD PMID:16221962 gentamycin increases expression ISO RGD:1305008 6480464 Gentamicins results in increased expression of SUCLG2 mRNA, Gentamicins results in increased expression of SUCLG2 protein CTD PMID:22061828 glyphosate decreases expression ISO RGD:1305008 6480464 glyphosate results in decreased expression of SUCLG2 mRNA CTD PMID:26302742 L-ascorbic acid affects expression EXP 6480464 Ascorbic Acid affects the expression of SUCLG2 protein CTD PMID:19224539 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SUCLG2 mRNA CTD PMID:20938992 methapyrilene decreases expression ISO RGD:1305008 6480464 Methapyrilene results in decreased expression of SUCLG2 protein CTD PMID:30467583 methotrexate affects response to substance ISO RGD:1312779 6480464 SUCLG2 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methyl methanesulfonate decreases expression ISO RGD:1312779 6480464 Methyl Methanesulfonate results in decreased expression of SUCLG2 mRNA CTD PMID:23649840 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of SUCLG2 mRNA CTD PMID:17383702 N-nitrosodiethylamine multiple interactions ISO RGD:1305008 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SUCLG2 mRNA CTD PMID:17602206 N-nitrosomorpholine affects expression ISO RGD:1305008 6480464 N-nitrosomorpholine affects the expression of SUCLG2 protein CTD PMID:19716841 okadaic acid decreases expression EXP 6480464 Okadaic Acid results in decreased expression of SUCLG2 mRNA CTD PMID:25270620 ozone multiple interactions ISO RGD:1312779 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SUCLG2 mRNA more ... CTD PMID:32699268 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SUCLG2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1312779 6480464 Acetaminophen results in decreased expression of SUCLG2 mRNA CTD PMID:25704631 , PMID:29067470 perfluorododecanoic acid increases expression ISO RGD:1305008 6480464 perfluorododecanoic acid results in increased expression of SUCLG2 protein CTD PMID:26168851 phenethyl isothiocyanate affects binding ISO RGD:1312779 6480464 SUCLG2 protein binds to phenethyl isothiocyanate CTD PMID:21838287 phenylmercury acetate decreases expression ISO RGD:1312779 6480464 Phenylmercuric Acetate results in decreased expression of SUCLG2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1312779 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of SUCLG2 mRNA CTD PMID:27188386 phlorizin decreases expression EXP 6480464 Phlorhizin results in decreased expression of SUCLG2 mRNA CTD PMID:22538082 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SUCLG2 mRNA CTD PMID:18301758 , PMID:23811191 potassium chromate decreases expression EXP 6480464 potassium chromateVI results in decreased expression of SUCLG2 protein CTD PMID:22144121 quercetin decreases expression ISO RGD:1312779 6480464 Quercetin results in decreased expression of SUCLG2 mRNA CTD PMID:21632981 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of SUCLG2 protein CTD PMID:25505154 SB 431542 multiple interactions ISO RGD:1312779 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 sodium nitrate multiple interactions EXP 6480464 sodium nitrate inhibits the reaction [Doxorubicin results in decreased expression of SUCLG2 protein] CTD PMID:21251210 sunitinib decreases expression ISO RGD:1312779 6480464 Sunitinib results in decreased expression of SUCLG2 mRNA CTD PMID:31533062 Tesaglitazar increases expression ISO RGD:1305008 6480464 tesaglitazar results in increased expression of SUCLG2 mRNA CTD PMID:21515302 tetrachloromethane decreases expression ISO RGD:1305008 6480464 Carbon Tetrachloride results in decreased expression of SUCLG2 mRNA CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SUCLG2 mRNA CTD PMID:31919559 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of SUCLG2 mRNA CTD PMID:29128614 , PMID:29264374 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SUCLG2 mRNA CTD PMID:29950665 urethane decreases expression ISO RGD:1312779 6480464 Urethane results in decreased expression of SUCLG2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1312779 6480464 Valproic Acid affects the expression of SUCLG2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1312779 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of SUCLG2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1312779 6480464 Valproic Acid results in decreased expression of SUCLG2 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:1312779 6480464 Valproic Acid results in decreased methylation of SUCLG2 gene CTD PMID:29501571 vinclozolin increases methylation ISO RGD:1305008 6480464 vinclozolin results in increased methylation of SUCLG2 gene CTD PMID:31079544